SLU-PP-332
aka SLUPP332
Immune Modulator
Mechanism
SLU-PP-332 is a small-molecule (non-peptide) pan-agonist of estrogen-related receptors ERRα/β/γ developed at Saint Louis University. Studied preclinically as an exercise mimetic in rodents, it has no human clinical data and is NOT FDA-approved. Sold only as a grey-market research chemical.
Identification
Vendors selling SLU-PP-332
No vendor listings on file yet.
Research
No citations on file yet.